Skip to main content

Drug metabolism & pharmacokinetics

Better predict pharmacokinetic (PK) and drug-drug interactions (DDIs) with DMPK/ADME studies and computational modeling on your compound, prior to clinical trials, to move quickly from discovery to development.
Request a consultation

Better predict metabolism and pharmacokinetics on your molecule

Partner with our expert scientists to gain a better understanding of your compound's metabolic profile and pharmacokinetic properties to make critical decisions throughout all phases of development.

DMPK & ADME capabilities

 

In vitro metabolism

Learn More

In vivo metabolism

  • In Vivo Metabolism
  • Fast PK | PK/TK Analysis & Reporting
  • Radiolabeled ADME | hAME
  • Bioequivalcence | Biosimilars
  • WBA
Learn More

MetID

  • Metabolite Identification (MetID)
  • Human AME
  • In Vitro / In Vivo Cross Species
  • Metabolic Stability
  • Radiolabeled ADME
Learn More

Pharmacometrics

Learn More

From early discovery to regulatory submission, our end-to-end non clinical development solutions help de risk your program, accelerate timelines, and optimize decision-making. With our deep scientific expertise, cutting-edge technology, and global regulatory insights, we provide the data and confidence you need to move forward.